Endotoxin desensitization of human mononuclear cells after cardiopulmonarybypass

Citation
U. Grundmann et al., Endotoxin desensitization of human mononuclear cells after cardiopulmonarybypass, ANESTHESIOL, 93(2), 2000, pp. 359-369
Citations number
31
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANESTHESIOLOGY
ISSN journal
00033022 → ACNP
Volume
93
Issue
2
Year of publication
2000
Pages
359 - 369
Database
ISI
SICI code
0003-3022(200008)93:2<359:EDOHMC>2.0.ZU;2-R
Abstract
Background: The ability of leukocytes to release proinflammatory cytokines on lipopolysaccharide stimulation in vitro is impaired after cardiopulmonar y bypass (CPB). This study tested contribution and interaction of humoral f actors In altered leukocyte responsiveness to lipopolysaccharide, Methods: Whole blood and isolated peripheral-blood mononuclear cells (PBMCs ) from 10 patients obtained after induction of anesthesia (T-1) and 20 min (T-2) and 24 h (T-3) after CPB were cultured in the absence or presence of lipopolysaccharide and assessed for release of tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-1 beta and their functional antagonists, I L-1 receptor antagonist (IL-1ra) and IL-10. In addition, dose-response char acteristics and interaction of IL-10 and norepinephrine as modulators of TN F-alpha release mere studied. Results: Cardiopulmonary bypass induced release of antiinflammatory (T-2: I L-10: median 25 pg/ml, 25th-75th percentile 9-42; IL1ra: median 1,528 pg/ml , 25th-75th percentile 1,075- 17,047; P < 0.05 compared with T-1) but faile d to induce proinflammatory cytokines (T-2: TNF-alpha: median 0 pg/ml, 25th -75th percentile 0-6; IL-1 beta: median 1 pg/ml, 25th-75th percentile 0-81; nonsignificant). Removal of plasma at T-2 increased TNF-alpha response to lipopolysaccharide (+83.8%; P < 0.05), whereas it suppressed IL-10 (-36.8%; P < 0.05). Similarly, incubation of PBMCs (T-1) with plasma obtained after CPB (T-2) as web as addition of IL-10 or norepinephrine in concentrations present in plasma after CPB led to a reduced lipopolysaccharide-stimulated TNF-alpha and an increased IL-10 response. Coadministration of norepinephri ne and IL-10 had synergistic effects. Although pretreatment with an anti-IL -10 antibody and labetalol before addition of plasma obtained at T-2 largel y restored the TNF-alpha response in vitro, their addition post-treatment f ailed to restore the monocytic TNF-alpha response. Conclusions: Plasma contains interacting factors that inhibit the release o f TNF-alpha and increase the release of IL-10, presumably attenuating the i nflammatory response to CPB, Although norepinephrine fails to induce a cyto kine response in the absence of other stimuli, its administration seems to augment the antiinflammatory IL-10 response while attenuating the TNF-alpha response.